Vaxtex Cotfab Limited VCL NSE
Vaxtex Cotfab Limited manufactures and sells textiles in India. The company offers denim fabrics, home textiles, jeans, men's casual shirts, printed fabrics, and yarns. It also provides shirting and suiting fabrics to various international brands, export houses, corporate buyers, domestic traders, wholesalers, and distributors. In addition, the company offers engineering solutions. Vaxtex Cotfab Limited was incorporated in 2005 and is based in Ahmedabad, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Excellent profit margin of 36.9%.
CONS
- Revenue declined at -56.1% CAGR over 5 years.
- Earnings shrank at -15.9% CAGR over 5 years.
- Trading 45.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | VCL Vaxtex Cotfab Limited NSE | 1.39 | 4.21 | ₹25.54 Cr | - | 2.04% | - | -56.06% | -15.91% |
| 2 | MARUTI Maruti Suzuki India Limited NIFTY50NSEAI | 13,127.00 | 28.09 | ₹4.13 L Cr | 1.07% | 17.22% | 14.43% | 16.60% | 21.11% |
| 3 | M&M Mahindra & Mahindra Limited NIFTY50NSEAI | 3,045.60 | 20.00 | ₹3.66 L Cr | 1.08% | 17.26% | 18.75% | 18.44% | 18.48% |
| 4 | TITAN Titan Company Limited NIFTY50NSE | 4,074.90 | 71.43 | ₹3.61 L Cr | 0.27% | 38.43% | 37.13% | 23.83% | 16.00% |
| 5 | ETERNAL Eternal Limited NSEAITECH | 250.58 | 626.45 | ₹2.30 L Cr | - | 2.87% | 1.19% | 97.70% | 45.90% |
| 6 | EICHERMOT Eicher Motors Limited NIFTY50NSEAI | 7,177.00 | 35.71 | ₹1.97 L Cr | 0.98% | 26.43% | 23.77% | 17.47% | 23.70% |
| 7 | TVSMOTOR TVS Motor Company Limited NSE | 3,355.70 | 52.91 | ₹1.59 L Cr | 0.36% | 28.86% | 31.62% | 26.91% | 31.46% |
| 8 | HYUNDAI HYUNDAI MOTOR INDIA LTD NSE | 1,924.00 | 28.82 | ₹1.56 L Cr | 1.09% | 32.62% | 29.92% | 5.50% | 4.87% |
| 9 | MOTHERSON Samvardhana Motherson International Limited NSEAI | 145.74 | 39.82 | ₹1.53 L Cr | 0.41% | 11.82% | 10.11% | 17.10% | 37.17% |
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 5.25 Cr | 0 | 8.88 Cr |
| Cost of Revenue | 0 | 0 | 5.26 Cr | 0 | 6.44 Cr |
| Gross Profit | 0 | 0 | -89,000 | 0 | 2.44 Cr |
| Operating Expenses | 13.13 L | 43.22 L | 10.21 L | 23.12 L | 12.13 L |
| Operating Income | -13.13 L | -43.22 L | -11.10 L | -23.12 L | 2.31 Cr |
| EBITDA | -8.73 L | -36.06 L | 96.71 L | 24.70 L | 3.87 Cr |
| Interest Expense | 1.69 L | 1.74 L | 6.18 L | 1.77 L | 1.86 L |
| Pretax Income | -11.91 L | -43.83 L | 89.10 L | 21.60 L | 3.85 Cr |
| Tax Provision | 0 | -4.70 L | -42.50 L | 0 | -9.39 L |
| Net Income | -11.91 L | -39.13 L | 1.32 Cr | 21.60 L | 3.95 Cr |
| Diluted EPS | -0.01 | -0.02 | - | 0.01 | 0.21 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 61.91 Cr | 67.04 Cr | 16.62 Cr | 5.25 Cr |
| Cost of Revenue | 54.05 Cr | 70.32 Cr | 21.86 Cr | 5.06 Cr |
| Gross Profit | 7.86 Cr | -3.28 Cr | -5.24 Cr | 19.75 L |
| Operating Expenses | 5.14 Cr | -3.34 Cr | 1.31 Cr | 80.24 L |
| Operating Income | 2.71 Cr | 6.39 L | -6.55 Cr | -60.49 L |
| EBITDA | 3.39 Cr | 2.07 Cr | -8.62 Cr | 62.83 L |
| Interest Expense | 1.08 Cr | 63.05 L | 6.54 L | 11.25 L |
| Pretax Income | 2.01 Cr | 1.16 Cr | -8.83 Cr | 41.16 L |
| Tax Provision | 52.29 L | 2.69 L | 0 | -47.20 L |
| Net Income | 1.49 Cr | 1.13 Cr | -8.83 Cr | 88.36 L |
| Diluted EPS | 0.14 | 0.10 | -0.59 | 0.05 |
Compounded Sales Growth
| 5 Years: | -56.06% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -15.91% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +39.00% |
| 6 Months: | -4.14% |
| 3 Months: | -33.17% |
| 1 Month: | -6.08% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 23.99 Cr | 69.48 Cr | 48.87 Cr | 48.47 Cr |
| Current Assets | 20.01 Cr | 65.76 Cr | 41.82 Cr | 40.90 Cr |
| Cash & Equivalents | 14.94 L | 9.30 L | 2.24 L | 48,000 |
| Inventory | 5.41 Cr | 1.34 Cr | 21.46 L | 0 |
| Receivables | 6.19 Cr | 18.22 Cr | 15.71 Cr | 13.98 Cr |
| Total Liabilities | 13.63 Cr | 46.00 Cr | 30.08 Cr | 30.13 Cr |
| Current Liabilities | 7.35 Cr | 40.59 Cr | 19.82 Cr | 22.78 Cr |
| Long Term Debt | 6.03 Cr | 5.18 Cr | 9.99 Cr | 7.35 Cr |
| Total Debt | 7.45 Cr | 5.19 Cr | 11.51 Cr | 11.13 Cr |
| Total Equity | 10.36 Cr | 23.48 Cr | 18.79 Cr | 18.34 Cr |
| Shares Outstanding | 10.56 Cr | 13.29 Cr | 18.38 Cr | 18.38 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 6.74 Cr | -10.90 Cr | -47.60 Cr | 1.23 Cr |
| Investing Cash Flow | -3.70 Cr | 33.73 L | 29.78 Cr | -76.04 L |
| Financing Cash Flow | -3.01 Cr | 10.51 Cr | 17.75 Cr | -48.71 L |
| Capital Expenditure | -35.80 L | -2.31 L | - | - |
| Free Cash Flow | 6.38 Cr | -10.92 Cr | -47.60 Cr | 1.23 Cr |
| Net Change in Cash | 3.55 L | -5.64 L | -7.06 L | -1.76 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 12.7% | -4.9% | -31.6% | 3.8% |
| Operating Margin % | 4.4% | 0.1% | -39.4% | -11.5% |
| Net Margin % | 2.4% | 1.7% | -53.2% | 16.8% |
| ROE % | 14.3% | 4.8% | -47.0% | 4.8% |
| ROCE % | 16.3% | 0.2% | -22.6% | -2.4% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VCL